Meng Zhang
Impact in
- Cancer Research top 0.2%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Immunology top 0.5%
Papers in
- Cancer Research 150
- Cancer-related molecular mechanisms research 61
- MicroRNA in disease regulation 52
- Immunology 118
- Immune Cell Function and Interaction 32
- Journals
- Frontiers in Immunology (14 papers)Frontiers in Oncology (13 papers)Scientific Reports (12 papers)Medicine (11 papers)PLoS ONE (11 papers)
- Partner nations
- ChinaUnited StatesAustralia
In The Last Decade
Meng Zhang
807 papers receiving 16.6k citations
Hit Papers
Peers
Comparison fields: 5 of 198
- Cancer Research 3.3k
- Immunology 2.5k
- Molecular Biology 7.0k
- Oncology 2.4k
- Biomaterials 1.0k
Countries citing papers authored by Meng Zhang
This map shows the geographic impact of Meng Zhang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Meng Zhang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Meng Zhang more than expected).
Fields of papers citing papers by Meng Zhang
This network shows the impact of papers produced by Meng Zhang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Meng Zhang. The network helps show where Meng Zhang may publish in the future.
Co-authors
The 25 scholars most cited alongside Meng Zhang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 0 | |
| 4 | 2025 | 0 | |
| 5 | 2024 | 6 | |
| 6 | 2024 | 6 | |
| 7 | 2024 | 1 | |
| 8 | 2024 | 0 | |
| 9 | 2024 | 3 | |
| 10 | 2024 | 0 | |
| 11 | 2024 | 0 | |
| 12 | 2023 | 16 | |
| 13 | 2023 | 8 | |
| 14 | 2023 | 2 | |
| 15 | 2023 | 6 | |
| 16 | 2023 | 8 | |
| 17 | 2023 | 1 | |
| 18 | 2023 | 13 | |
| 19 | 2009 | 27 | |
| 20 | 2007 | 3 |
About Meng Zhang
Meng Zhang is a scholar working on Cancer Research, Immunology, Oncology, Molecular Biology and Pulmonary and Respiratory Medicine, having authored 861 papers that have together received 16.7k indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (61 papers), MicroRNA in disease regulation (52 papers), Ferroptosis and cancer prognosis (46 papers), Nanoplatforms for cancer theranostics (44 papers), RNA modifications and cancer (43 papers), Epigenetics and DNA Methylation (41 papers), Immune Cell Function and Interaction (32 papers) and Circular RNAs in diseases (29 papers). The work is most often cited by research in Cancer Research (3.3k citations), Immunology (2.5k citations), Molecular Biology (7.0k citations), Oncology (2.4k citations) and Biomaterials (1.0k citations). Meng Zhang has collaborated with scholars based in China, United States and Australia. Frequent co-authors include Wenbo Bu, Yanyan Liu, Zhongmin Tang, Chang Yin Liang, Ruixue Song, Peiran Zhao, Xiang Du, Zhenwei Yao, Mingyuan He and Xianfu Meng. Their work appears in journals such as Frontiers in Immunology, Frontiers in Oncology, Scientific Reports, Medicine and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.